These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Responsiveness to inhaled NO in isolated-perfused lungs from endotoxin-challenged rats is dependent on endogenous nitrite/nitrate synthesis. Bopp Ch, Gust R, Taut F, Gries A, Martin E, Klein A. Eur J Anaesthesiol; 2007 Apr; 24(4):362-9. PubMed ID: 17094870 [Abstract] [Full Text] [Related]
13. Effects of intravenous Zaprinast and inhaled nitric oxide on pulmonary hemodynamics and gas exchange in an ovine model of acute respiratory distress syndrome. Adrie C, Holzmann A, Hirani WM, Zapol WM, Hurford WE. Anesthesiology; 2000 Aug; 93(2):422-30. PubMed ID: 10910492 [Abstract] [Full Text] [Related]
14. Low-dose systemic phosphodiesterase inhibitors amplify the pulmonary vasodilatory response to inhaled prostacyclin in experimental pulmonary hypertension. Schermuly RT, Ghofrani HA, Enke B, Weissmann N, Grimminger F, Seeger W, Schudt C, Walmrath D. Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1500-6. PubMed ID: 10556112 [Abstract] [Full Text] [Related]
15. The cGMP phosphodiesterase inhibitor zaprinast enhances the effect of nitric oxide. Thusu KG, Morin FC, Russell JA, Steinhorn RH. Am J Respir Crit Care Med; 1995 Nov; 152(5 Pt 1):1605-10. PubMed ID: 7582302 [Abstract] [Full Text] [Related]
16. Effects of various selective phosphodiesterase inhibitors on carbachol-induced contraction and cyclic nucleotide contents in guinea pig taenia coli. Kaneda T, Shimizu K, Urakawa N, Nakajyo S. J Vet Med Sci; 2004 Sep; 66(9):1047-52. PubMed ID: 15472466 [Abstract] [Full Text] [Related]
17. Pulmonary responses to selective phosphodiesterase-5 and phosphodiesterase-3 inhibitors. Matot I, Gozal Y. Chest; 2004 Feb; 125(2):644-51. PubMed ID: 14769749 [Abstract] [Full Text] [Related]
18. The type III phosphodiesterase inhibitor milrinone and type V PDE inhibitor dipyridamole individually and synergistically reduce elevated pulmonary vascular resistance. Clarke WR, Uezono S, Chambers A, Doepfner P. Pulm Pharmacol; 1994 Apr; 7(2):81-9. PubMed ID: 8081075 [Abstract] [Full Text] [Related]